A very recent study reported that NCKIPSD downregulation and increased α-tubulin acetylation promotes stiffness of tumor stroma, which in turn, may inhibit chemotherapeutic drug uptake and regulate tumor sensitivity to chemotherapy, resulting in high risk of breast cancer recurrence within 5 years (You et al., 2017). The gene discussed is NCKIPSD; the disease is breast cancer.